ArticleCureus2026
Diagnostic Challenge of Recurrent Dermatofibrosarcoma Protuberans Mimicking Other Spindle Cell Lesions: Importance of Immunohistochemistry in Diagnosis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatofibrosarcoma protuberans (DFSP) is an uncommon, low-grade cutaneous sarcoma with fibroblastic differentiation. It typically shows slow progression but is locally aggressive and has a tendency for recurrence if not adequately excised. Although metastasis is rare, DFSP often infiltrates deeper tissues and may closely resemble other benign spindle cell lesions both clinically and on routine histology, creating diagnostic difficulty. Immunohistochemistry plays a crucial supportive role in assisting with the diagnostic workup. We report a 54-year-old male who presented with a painless swelling over the right scapular region. The lesion was initially diagnosed in 2019 as a benign spindle cell lesion on core needle biopsy and excision biopsy. He developed a recurrence at the same site in 2022, which was again reported as a spindle cell lesion with differentials including fibromatosis, DFSP. In 2024, the patient returned with a progressively enlarging mass at the same location, following which a wide local excision was performed. Histopathological examination showed features consistent with DFSP and immunohistochemistry revealed diffuse CD34 positivity. The tumor was found to infiltrate skeletal muscle and extend up to the deep surgical margin. This case highlights the diagnostic pitfalls of DFSP, particularly when it presents as a recurrent spindle cell lesion and mimics benign entities such as fibromatosis. Careful histopathological evaluation supported by immunohistochemistry is essential for timely diagnosis and appropriate surgical management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.